Delivery Order SPE2DB22D3301-SPE2DB25FY7FJ

Award Date 7/2/25
Potential Completion Date 7/24/25
Potential Value $21K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $21,325.14 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a period of performance through July 3, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,871.50 firm fixed-price contract is for the delivery of TAGRISSO 40 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $10,903.03, is for the supply of TAGRISSO 80 MG TABLET 30S, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a $30,917.04 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of September 10, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which enables DLA to efficiently procure a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug TAGRISSO 80 MG TABLET 30S. The contract has a firm fixed price of $10,662.57 and a period of performance through July 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive...
This is a $10,662.57 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication TAGRISSO 80 MG TABLET 30S, with a period of performance through July 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,325.14 contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a pharmaceutical product, with a period of performance ending on February 14, 2025. The contract is a firm-fixed-price type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a $10,662.57 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAGRISSO 80 MG TABLET 30S. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
This is a $10,538.79 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for TAGRISSO 80 MG TABLET 30S, a specialty medication. The delivery order is placed under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a comprehensive range of medical commodities to support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $73,771.53 firm fixed-price contract provides the DLA with TAGRISSO 80 MG TABLET 30S, a specialty medication. The contract has a period of performance through July 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7FJ
    Delivery Order

This is a $21,325.14 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAGRISSO 80 MG TABLET 30S, a prescription medication, with a performance period ending on July 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs through December 2026. The contract is a firm fixed-price, non-set-aside award, indicating open competition.

Generated 10/1/25, 9:52 AM